Paper19330833
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?
Näsman A and 16 others. Int J Cancer, 2009. Cited by 578 papers, by iCite.
Cite this record
ConductScience Library. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Papers, record 19330833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19330833
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Papillomaviridae | Major topic |
| Papillomavirus Infections | Major topic |
| Tonsillar Neoplasms | Major topic |
| Base Sequence | |
| DNA Primers | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Middle Aged | |
| Prevalence | |
| Sweden |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01358097 | Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy | Background | ClinicalTrials.gov | |
| NCT01706939 | The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer | Background | ClinicalTrials.gov | |
| NCT02945631 | Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer | Background | ClinicalTrials.gov |
Cited by292
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 578 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926887 | Income-related differences in survival across disease categories in Sweden: a retrospective population-based register study. | Lancet Reg Health Eur | 2026 | https://conductscience.org/library/papers/42926887 | PubMed |
| 42769913 | Promoting expertise knowledge sharing in paediatric virology: An update (Review). | Exp Ther Med | 2026 | https://conductscience.org/library/papers/42769913 | PubMed |
| 42471999 | Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42471999 | PubMed |
| 41910910 | Inter-rater reliability of MRI Neck Imaging Reporting and Data System (NI-RADS) in the follow-up of oropharyngeal squamous cell carcinoma. | Radiol Med | 2026 | https://conductscience.org/library/papers/41910910 | PubMed |
| 41682871 | Routine Histopreparations After Tonsillectomy, Tonsillotomy, Adenotomy or Conchotomy: A Necessary Diagnosis in Times of Dwindling Resources? | J Clin Med | 2026 | https://conductscience.org/library/papers/41682871 | PubMed |
| 41419643 | Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment. | Sci Rep | 2025 | https://conductscience.org/library/papers/41419643 | PubMed |
| 41333028 | Potential anticancer effects of Peganum harmala in human papillomavirus-related cervical and head and neck cancer cells. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41333028 | PubMed |
| 41158234 | Prognostic and predictive roles of circulating microRNAs as biomarkers in head and neck cancer patients in the Northern Territory, Australia undergoing chemoradiotherapy-a pilot prospective cohort study. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/41158234 | PubMed |
| 41129372 | Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC). | Int J Cancer | 2026 | https://conductscience.org/library/papers/41129372 | PubMed |
| 40679652 | Predictive and prognostic value of inflammatory factors (IL-6, IL-8, and TNF-α) in saliva for radiotherapy response in patients with HPV-associated oropharyngeal squamous cell carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40679652 | PubMed |
| 40490828 | Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population. | Infect Agent Cancer | 2025 | https://conductscience.org/library/papers/40490828 | PubMed |
| 40331509 | Defining the Molecular Intricacies of Human Papillomavirus-Associated Tonsillar Carcinoma. | Cancer Control | 2025 | https://conductscience.org/library/papers/40331509 | PubMed |
| 40246777 | Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer. | J Intern Med | 2025 | https://conductscience.org/library/papers/40246777 | PubMed |
| 39941727 | Risk Stratification in HPV-Associated Oropharyngeal Cancer: Limitations of Current Approaches and the Search for Better Solutions. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941727 | PubMed |
| 39840027 | A Qualitative Study of Attitudes Toward HPV Vaccine Recommendation in Otolaryngology Clinics. | Laryngoscope Investig Otolaryngol | 2025 | https://conductscience.org/library/papers/39840027 | PubMed |
| 39124727 | Transoral Robotic Surgery and Human Papillomavirus Infection: Impact on Oropharyngeal Cancer Prognosis. | J Clin Med | 2024 | https://conductscience.org/library/papers/39124727 | PubMed |
| 38987693 | PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38987693 | PubMed |
| 38920638 | Moderate SCRIB Expression Levels Correlate with Worse Prognosis in OPSCC Patients Regardless of HPV Status. | Cells | 2024 | https://conductscience.org/library/papers/38920638 | PubMed |
| 38918827 | Immunoreactivity of LMO7 and other molecular markers as potential prognostic factors in oropharyngeal squamous cell carcinoma. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/38918827 | PubMed |
| 38440648 | Association of Human Papillomavirus Infection with Tonsillar Cancers: A Systematic Review. | Indian J Otolaryngol Head Neck Surg | 2024 | https://conductscience.org/library/papers/38440648 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19330833
GET https://conductscience.org/api/papers/v1/19330833/cited_by?page=2